May 16, 2025, China – Wixbio’s CEO, head of the overseas business division, and Middle East sales manager visited Iran in mid-May to visit and evaluate the ICD Group. The visit aimed to strengthen the partnership between the two companies and engage in in-depth discussions and negotiations on future collaboration in animal healthcare.
During the visit, the Wixbio delegation held several meetings with ICD Group’s board members, diving into current market trends, technological advancements, and shared interests. With mutual respect and shared goals, both sides discussed their strengths and needs in depth, reaching broad agreement on future partnership directions.
After a series of productive negotiations, Wixbio and the ICD Group signed a partnership agreement. The agreement outlines comprehensive collaboration in areas like product supply, technological research and development, and market expansion. This will boost both companies’ global market competitiveness and support the local livestock industry’s growth.
Wixbio’s CEO stated: “We’re thrilled to partner strategically with Iran’s ICD Group. Through our joint efforts, we believe we can deliver more high-quality animal healthcare products and services to customers, contributing significantly to the global livestock industry’s healthy growth.”
This partnership marks another major step for Wixbio in the international market, showing the company’s dedication to global partnerships and growth.
